Adel Djermane

Dr. Adel Djermane

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2016 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
Adel DjermaneAdel Djermane
Adel Djermane
MEMonique Elmaleh-Bergès
Monique Elmaleh-Bergès
DSDominique Simon
Dominique Simon
APAmélie Poidvin
Amélie Poidvin
JCJean-Claude Carel
Jean-Claude Carel
JLJuliane Léger
Juliane Léger
Context: Neonatal central diabetes insipidus (CDI) with or without adipsia is a very rare complication of various complex hypothalamic disorders. It is associated with greater morbidity and a high risk of developing both hypernatremia and hyponatremia, due to the condition itself or secondary to treatment with vasopressin analogs or fluid administration. Its outcomes have yet to be evaluated.Objective: To investigate the clinical outcomes of patients with neonatal-onset CDI or adipsic CDI with hypernatremia.Design, Setting, and Participants: All patients diagnosed with neonatal CDI in a university hospital-based observational study and followed between 2005 and 2015 were included and analyzed retrospectively.Main Outcome Measures: The various causes of CDI were grouped. Clinical outcome and comorbidities were analyzed.Results: Ten of the 12 patients had an underlying condition with brain malformations: optic nerve hypoplasia (n = 3), septo-optic dysplasia (n = 2), semilobar holoprosencephaly (n = 1), ectopic neurohypophysis (n = 3), and unilateral absence of the internal carotid artery (n = 1). The other two were idiopathic cases. During the median follow-up period of 7.8 (4.9–16.8) years, all but one patient displayed anterior pituitary deficiency. Transient CDI was found in three (25%) patients for whom a posterior pituitary hyperintense signal was observed with (n = 2) and without (n = 1) structural hypothalamic pituitary abnormalities, and with no other underlying cerebral malformations. Patients with permanent CDI with persistent adipsia (n = 4) and without adipsia (n = 5) required adequate fluid intake and various doses of desamino-D-arginine-8-vasopressin. Those with adipsia were more likely to develop hypernatremia (45 vs 33%), hyponatremia (16 vs 4%) (P < .0001), and severe neurodevelopmental delay (P < .05) than those without adipsia. Comorbidities were common. The underlying cause remains unknown at the age of 23 years for one patient with CDI and normal thirst.Conclusion: Neonatal CDI may be transient or permanent. These vulnerable patients have high rates of comorbidity and require careful monitoring.

5 February 2018 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
MBMeriem Bensalah
Meriem Bensalah
MDMalcolm Donaldson
Malcolm Donaldson
YAYamina Aribi
Yamina Aribi
MIMalek Iabassen
Malek Iabassen
LCLyes Cherfi
Lyes Cherfi
SOSamia OuldKablia
Samia OuldKablia

6 January 2025 in Hormone Research in Paediatrics
Verified
Journal Article
Closed access
Asmahane LadjouzeAsmahane Ladjouze
Asmahane Ladjouze
YOYasmina Ouarezki
Yasmina Ouarezki
Adel DjermaneAdel Djermane
Adel Djermane
SKSakina Kherra
Sakina Kherra
MBMeriem Bensalah
Meriem Bensalah
GVGuy Van Vliet
Guy Van Vliet
Introduction:Screening for congenital adrenal hyperplasia through the measurement of 17-hydroxyprogesterone on the neonatal blood spot aims to: a) prevent neonatal deaths; b) allow earlier identification and thereby decrease the severity of the initial salt-wasting episode; and c) shorten the time during which a severely virilized genetic female newborn may be assigned the male sex. It is now practiced in the majority of high-income countries, although the positive predictive value of the test is very low in infants born preterm, who seem to be infrequently affected. In almost all low- and middle-income countries, it has not yet been implemented. Methods:To determine if it is justified in such a country, we evaluated the prevalence of premature birth and the sex ratio in a cohort of 299 singleton Algerian infants diagnosed with congenital adrenal hyperplasia. Results: Only 4% were born before 37 weeks of gestational age, less than the 14.3% observed in the general Algerian population. None was born before 34 weeks of gestation. The salt-wasting form of the disease was confirmed in 93 boys and 139 girls. Conclusion: We speculate that the combination of a high production of 17-hydroxyprogesterone with a low production of cortisol by the fetus with congenital adrenal hyperplasia accounts for the rarity of very preterm birth in this population. We suggest that newborn screening for congenital adrenal hyperplasia is necessary in Algeria to equalize the sex ratio but that it could be restricted to neonates born after 32 weeks of gestation, thereby possibly improving the cost-effectiveness ratio of this intervention.

Verified
Journal Article
Open access
PDF file
Adel DjermaneAdel Djermane
Adel Djermane
YOYasmina Ouarezki
Yasmina Ouarezki
KBKamelia Boulesnane
Kamelia Boulesnane
SKSakina Kherra
Sakina Kherra
FBFadila Bouferoua
Fadila Bouferoua
Asmahane LadjouzeAsmahane Ladjouze
Asmahane Ladjouze
The absence of biochemical newborn screening (NBS) delays the diagnosis and treatment of congenital hypothyroidism (CH), resulting in irreversible neurodevelopmental damage. To determine the age at diagnosis for CH among Algerian children and to describe its clinical and biological characteristics, etiology, and outcome, we conducted a multicenter retrospective cohort study involving 288 children with CH across 20 pediatric centers between 2005 and 2023. The median age at diagnosis was 1.6 months, and only 28% of patients started treatment before 30 days. Prolonged neonatal jaundice was the most frequently presented symptom (58%), severe CH (fT4 < 5 pmol/L) was observed in 35% and 52% received an insufficient initial dose of L-T4. The median IQ of the 47 patients tested was 86; 11% had an IQ < 70, and a negative correlation was found between age at diagnosis and IQ (r = −0.48, p = 0.001). In children reassessed at age 3, 51% had normal thyroid function, indicating transient CH. Delayed diagnosis and suboptimal treatment of CH remain major challenges in Algeria, leading to substantial neurodevelopmental deficits. Pediatricians must remain cognizant of early clinical signs of CH to allow for timely diagnosis and intervention. Biochemical NBS for CH in Algeria is needed.

11 August 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Adel DjermaneAdel Djermane
Adel Djermane
YOYasmina Ouarezki
Yasmina Ouarezki
KBKamelia Boulesnane
Kamelia Boulesnane
SKSakina Kherra
Sakina Kherra
FBFadila Bouferoua
Fadila Bouferoua
Asmahane LadjouzeAsmahane Ladjouze
Asmahane Ladjouze
Background: The absence of biochemical newborn screening (NBS) delays the diagnosis and treatment of congenital hypothyroidism (CH), resulting in irreversible neurodevelop-mental damage. To determine the age at diagnosis of CH in Algerian children and to de-scribe its clinical and biological characteristics, etiology, and outcome, we conducted a multicenter retrospective cohort study involving 288 children with CH across 20 pediatric centers between 2005 and 2023. The median age at diagnosis was 1.6 months, and only 28% of patients started treatment before 30 days. Prolonged neonatal jaundice was the most frequent presenting symptom (58%), severe CH (fT4 < 5 pmol/L) was observed in 35% and 52% received an insufficient initial dose of L-T4. The median IQ of the 47 patients tested was 86, 11% had an IQ <70 and a negative correlation was found between age at diagnosis and IQ (r = -0.48, p = 0.001). In children reassessed at age 3, 51% had normal thyroid function, indicating transient CH. Delayed diagnosis and suboptimal treatment of CH remain major challenges in Algeria, leading to substantial neurodevelopmental deficits and highlights the urgent need for implanting a national NBS. Pediatricians must remain cognizant of early clinical signs of CH to allow timely diagnosis and intervention.